Status:

COMPLETED

Efficacy of Dexamethasone or Adrenaline in Inferior Alveolar Nerve Block

Lead Sponsor:

Tribhuvan University, Nepal

Collaborating Sponsors:

National Medical College, Birgunj, Nepal

Conditions:

Oral Surgical Procedure

Eligibility:

All Genders

18-60 years

Phase:

PHASE3

Brief Summary

Oral and dental professionals were responsible for the discovery of anaesthesia, given their close day-to-day contact with pain and, hence, their motivation to seek the means to alleviate it. Currentl...

Detailed Description

Background : Oral and dental professionals were responsible for the discovery of anaesthesia, given their close day-to-day contact with pain and, hence, their motivation to seek the means to alleviat...

Eligibility Criteria

Inclusion

  • patients above age 18 who need oral surgery under local anaesthesia and could understand and willing to take part in the study were selected.
  • contraindications to Dexamethasone (i.e., peptic ulcer, renal insufficiency, pregnant women or lactating females ),
  • allergy to NSAIDs ie piroxicam
  • ASA physical status \> III
  • any type of surgery other than a mention surgery performed under general anaesthesia
  • -patients with any condition precluding the limitation of intra-operative trial drugs ( lignocaine, adrenaline) administration (i.e., significant coronary artery disease, congestive heart failure)
  • those receiving any premedications (including opioids, benzodiazepines, and clonidine )
  • antibiotics or anti-inflammatory drugs within two weeks of the study entry. Also, radiograph showing high and bifid mandibular foramen were non included.

Exclusion

  • Subject who had to consume analgesic drugs other than the piroxicam 20 mg
  • The subjects who did not respond on the VAS scale for 24 hourly and did not come for follow-up for 2nd and 7th postoperatively.

Key Trial Info

Start Date :

August 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2021

Estimated Enrollment :

83 Patients enrolled

Trial Details

Trial ID

NCT04850885

Start Date

August 1 2020

End Date

February 28 2021

Last Update

April 22 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Saroj Prasad Deo

Birgunj, Two, Nepal, 43000